BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 16374372)

  • 1. Acute pancreatitis: models, markers, and mediators.
    Granger J; Remick D
    Shock; 2005 Dec; 24 Suppl 1():45-51. PubMed ID: 16374372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological mechanisms of acute pancreatitis define inflammatory markers of clinical prognosis.
    Minkov GA; Halacheva KS; Yovtchev YP; Gulubova MV
    Pancreas; 2015 Jul; 44(5):713-7. PubMed ID: 26061557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease.
    Fiotti N; Giansante C; Ponte E; Delbello C; Calabrese S; Zacchi T; Dobrina A; Guarnieri G
    Atherosclerosis; 1999 Jul; 145(1):51-60. PubMed ID: 10428295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor and platelet-activating factor antagonists in acute pancreatitis.
    Johnson CD
    Dig Surg; 1999; 16(2):93-101. PubMed ID: 10207233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications.
    Mayer J; Rau B; Gansauge F; Beger HG
    Gut; 2000 Oct; 47(4):546-52. PubMed ID: 10986216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis.
    de Beaux AC; Goldie AS; Ross JA; Carter DC; Fearon KC
    Br J Surg; 1996 Mar; 83(3):349-53. PubMed ID: 8665189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The importance of cytokines in the posttraumatic inflammatory reaction].
    Hildebrand F; Pape HC; Krettek C
    Unfallchirurg; 2005 Oct; 108(10):793-4, 796-803. PubMed ID: 16175346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of severe acute pancreatitis treated with CTR-001 direct hemoperfusion for cytokine apheresis.
    Saotome T; Endo Y; Sasaki T; Tabata T; Hamamoto T; Fujino K; Andoh A; Eguchi Y; Tani T; Fujiyama Y
    Ther Apher Dial; 2005 Aug; 9(4):367-71. PubMed ID: 16076384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis.
    Brivet FG; Emilie D; Galanaud P
    Crit Care Med; 1999 Apr; 27(4):749-55. PubMed ID: 10321665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory mediators in acute pancreatitis.
    Bhatia M; Brady M; Shokuhi S; Christmas S; Neoptolemos JP; Slavin J
    J Pathol; 2000 Feb; 190(2):117-25. PubMed ID: 10657008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascites fluid in severe acute pancreatitis: from pathophysiology to therapy.
    Dugernier T; Laterre PF; Reynaert MS
    Acta Gastroenterol Belg; 2000; 63(3):264-8. PubMed ID: 11189983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines and organ failure in acute pancreatitis: inflammatory response in acute pancreatitis.
    Malmstrøm ML; Hansen MB; Andersen AM; Ersbøll AK; Nielsen OH; Jørgensen LN; Novovic S
    Pancreas; 2012 Mar; 41(2):271-7. PubMed ID: 21956639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oleuropein on serum inflammatory cytokines and histopathological changes in rats with pancreatitis.
    Caglayan K; Güngör B; Cinar H; Avci B; Gur S; Arslan N
    Adv Clin Exp Med; 2015; 24(2):213-8. PubMed ID: 25931351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory mediators as therapeutic targets in acute pancreatitis.
    Bhatia M; Neoptolemos JP; Slavin J
    Curr Opin Investig Drugs; 2001 Apr; 2(4):496-501. PubMed ID: 11566005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis.
    Norman J; Franz M; Messina J; Riker A; Fabri PJ; Rosemurgy AS; Gower WR
    Surgery; 1995 Jun; 117(6):648-55. PubMed ID: 7539942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-cytokine strategies in acute pancreatitis: pathophysiological insights and clinical implications.
    Rau BM; Krüger CM; Schilling MK
    Rocz Akad Med Bialymst; 2005; 50():106-15. PubMed ID: 16358948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukins and their antagonists but not TNF and its receptors are released in post-ERP pancreatitis.
    Messmann H; Vogt W; Falk W; Vogl D; Zirngibl H; Leser HG; Schölmerich J
    Eur J Gastroenterol Hepatol; 1998 Jul; 10(7):611-7. PubMed ID: 9855088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of portal blood on the development of systemic inflammation associated with experimental acute pancreatitis.
    Hoyos S; Granell S; Heredia N; Bulbena O; Closa D; Fernández-Cruz L
    Surgery; 2005 Feb; 137(2):186-91. PubMed ID: 15674200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of therapeutic cytokine manipulation in acute pancreatitis.
    Denham W; Norman J
    Surg Clin North Am; 1999 Aug; 79(4):767-81. PubMed ID: 10470326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
    Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K
    Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.